Traders should monitor for future Form 4 filings to see if CPPIB converts preferred shares or adjusts its position. While this is a passive stake, the involvement of a large institutional investor like CPPIB may signal confidence in KLRA’s long-term prospects, though no active engagement is indicated.
Price Chart
Executive Summary
Canada Pension Plan Investment Board (CPPIB) and its subsidiary CPP Investment Board Private Holdings (4) Inc. filed an initial Form 3 disclosing indirect beneficial ownership of 5,000,000 shares of Kailera Therapeutics common stock, stemming from holdings of Series B Preferred Stock which are convertible into common stock on a one-to-one basis. This represents a new passive investment position by a major institutional investor.
Key Facts
- CPPIB is reporting indirect beneficial ownership of 5,000,000 shares of KLRA common stock
- The shares are held through convertible Series B Preferred Stock held by wholly-owned subsidiary CPP Investment Board Private Holdings (4) Inc.
- Each share of Series B Preferred Stock is convertible into one share of common stock at the holder's option, with no expiration date
- This is an initial Form 3 filing, indicating a new position or first-time reporting obligation
Financial Impact
5,000,000 shares of common stock equivalent, based on convertible preferred holdings
Risk Factors
- Potential future conversion of preferred stock could increase common share float and exert downward pressure on the stock price
- CPPIB may sell or reduce its position in the future, particularly if clinical or financial performance disappoints
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-159467 |
| Document: 0001193125-26-159467-index.html | 0001193125-26-159467 |
| Document: 0001193125-26-159467.txt | 0001193125-26-159467 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | 3 | $14.91 $12.92 | ▼ −13.35% | ▼ −12.85% | $10.39 (−30.32%) |
Aug 12, 2026 7w ago | 8-K | $17.97 $17.47 | ▼ −2.78% | ▼ −0.82% | $10.39 (−42.18%) |
Jul 31, 2026 9w ago | Court Ruling | $16.94 $18.66 | ▲ +10.15% | ▲ +6.64% | $10.39 (−38.67%) |
Jul 24, 2026 10w ago | Court Ruling | $17.69 $17.05 | ▼ −3.62% | ▼ −3.99% | $10.39 (−41.27%) |
Jun 5, 2026 16w ago | Press Release | $19.70 $19.67 | ▼ −0.15% | ▼ −2.26% | $10.39 (−47.26%) |
May 26, 2026 18w ago | 8-K | $21.91 $22.38 | ▲ +2.15% | ▲ +1.68% | $10.39 (−52.58%) |
May 26, 2026 18w ago | Press Release | $21.91 $22.59 | ▲ +3.10% | ▲ +1.90% | $10.39 (−52.58%) |
May 13, 2026 20w ago | Press Release | $21.11 $19.62 | ▼ −7.06% | ▼ −5.90% | $10.39 (−50.78%) |
Apr 20, 2026 23w ago | 8-K | $25.22 $23.82 | ▼ −5.55% | ▼ −6.63% | $10.39 (−58.80%) |
Apr 20, 2026 23w ago | Insider Cluster | $24.61 $23.51 | ▼ −4.47% | ▼ −5.38% | $10.39 (−57.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access